We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.85B
AUM Growth
+$678M
Cap. Flow
-$555M
Cap. Flow %
-8.1%
Top 10 Hldgs %
43.77%
Holding
155
New
30
Increased
19
Reduced
23
Closed
29

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$156M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$119M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$90.9M
4
RLAY icon
Relay Therapeutics
RLAY
+$88.8M
5
CHRS icon
Coherus Oncology
CHRS
+$57.5M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$133M
2
KOD icon
Kodiak Sciences
KOD
+$124M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$68.6M
4
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$54.9M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$52.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.2%
2 Miscellaneous 14.63%
3 Consumer Staples 0.6%
4 Financials 0.25%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
76
Establishment Labs
ESTA
$2.13B
$12.6M 0.18%
678,633
-57,488
-8% -$1.02M
PPH icon
77
PUT
VanEck Pharmaceutical ETF
PPH
$1B
$12.4M 0.18%
+200,000
New +$12.6M
DBVT
78
DBV Technologies
DBVT
$739M
$11.8M 0.17%
680,698
-51,083
-7% -$1.47M
ACCD
79
DELISTED
Accolade Inc
ACCD
$11.4M 0.17%
+293,138
New +$10.1M
HOLX
80
DELISTED
Hologic
HOLX
$11.3M 0.17%
170,000
-60,000
-26% -$3.8M
HCAT icon
81
Health Catalyst
HCAT
$129M
$10.7M 0.16%
291,084
-44,698
-13% -$1.52M
SCPE.U
82
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
$10.6M 0.15%
1,000,000
– –
TSHA icon
83
Taysha Gene Therapies
TSHA
$1.65B
$10.5M 0.15%
+470,440
New +$11.1M
TARA icon
84
Protara Therapeutics
TARA
$222M
$10.2M 0.15%
+608,544
New +$14.1M
PODD icon
85
Insulet
PODD
$9.66B
$8.93M 0.13%
37,733
-15,000
-28% -$3.16M
ATRC icon
86
AtriCure
ATRC
$2.86B
$8.64M 0.13%
216,449
-312,327
-59% -$13.2M
VRAY
87
DELISTED
ViewRay, Inc.
VRAY
$8.58M 0.13%
2,451,748
– –
AMRS
88
DELISTED
Amyris Inc.
AMRS
$8.57M 0.13%
3,333,332
+1,488,720
+81% +$5.46M
TWST icon
89
Twist Bioscience
TWST
$9.16B
$8.57M 0.13%
112,756
-160,000
-59% -$9.96M
AQST icon
90
Aquestive Therapeutics
AQST
$604M
$8.5M 0.12%
1,750,000
– –
TCRR
91
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$8.13M 0.12%
+400,000
New +$7.02M
DYN icon
92
Dyne Therapeutics
DYN
$3.34B
$8.08M 0.12%
+400,000
New +$8.78M
ONEM
93
DELISTED
1Life Healthcare
ONEM
$7.94M 0.12%
279,844
+61,000
+28% +$1.93M
RVMD icon
94
Revolution Medicines
RVMD
$43.9B
$7.8M 0.11%
224,224
-125,776
-36% -$3.48M
LGVW.U
95
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
$7.11M 0.1%
700,000
– –
PSTX
96
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$6.99M 0.1%
+787,745
New +$8.96M
TNGX icon
97
Tango Therapeutics
TNGX
$4.03B
$5.18M 0.08%
+500,000
New +$5.11M
OBIO icon
98
Orchestra BioMed
OBIO
$363M
$4.95M 0.07%
+450,000
New +$5.05M
VERU icon
99
Veru
VERU
$39.9M
$4.32M 0.06%
165,000
– –
TBIO
100
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$4.29M 0.06%
315,237
– –
2 3
4
5 6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Perceptive Advisors held 155 positions worth $6.85B, up 11% from $6.17B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perceptive Advisors withdrew a net $555M in Q3 2020, closing 29 positions and reducing 23 holdings. Its most notable exit was Zogenix, Inc., an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Outset Medical worth $142M.

  • Perceptive Advisors's largest Q3 2020 buy was Outset Medical: 189,855 shares worth $142M.
  • Perceptive Advisors added most to Mirati Therapeutics, Inc. Common Stock in Q3 2020, an estimated $90.9M increase.
  • Perceptive Advisors's biggest Q3 2020 reduction was Kodiak Sciences, cutting an estimated $124M.
  • Perceptive Advisors fully exited Zogenix, Inc. in Q3 2020, selling an estimated $133M.
  • Perceptive Advisors's ten largest holdings make up 44% of its $6.85B portfolio in Q3 2020.
  • Perceptive Advisors opened 30 new positions and closed 29 in Q3 2020.
  • Perceptive Advisors's portfolio value rose 11% quarter-over-quarter to $6.85B.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.